NXGL
NXGL
NASDAQ · Health Care

Nexgel Inc

$0.18
+0.00 (+2.30%)
As of Sep 28, 10:39 PM ET ·
Financial Highlights (FY 2026)
Revenue
27.51M
Net Income
-7,226,592
Gross Margin
39.5%
Profit Margin
-26.3%
Rev Growth
+77.3%
D/E Ratio
0.20
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.5% 39.5% 62.3% 62.3%
Operating Margin -27.9% -25.1% 15.0% 15.7%
Profit Margin -26.3% -25.0% 11.4% 15.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 27.51M 15.52M 5.33M 4.69M
Gross Profit 10.86M 6.13M 3.32M 2.92M
Operating Income -7,683,080 -3,900,480 798.7K 735.9K
Net Income -7,226,592 -3,668,734 604.4K 705.4K
Gross Margin 39.5% 39.5% 62.3% 62.3%
Operating Margin -27.9% -25.1% 15.0% 15.7%
Profit Margin -26.3% -25.0% 11.4% 15.0%
Rev Growth +77.3% +77.3% +6.5% +7.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 270.0K 270.0K 6.23M 5.69M
Total Equity 1.35M 1.35M 8.36M 7.17M
D/E Ratio 0.20 0.20 0.75 0.79
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,900,455 -3,161,908 1.03M 893.3K
Free Cash Flow — — 660.3K 478.5K